Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Open accessThe DOI matches its Crossref record; 144 of the 146 references it cites were found in a registry or an index.
Abstract
Candidemia, the commonest invasive fungal infection, is associated with high morbidity and mortality in developing countries, though the exact prevalence is not known due to lack of systematic epidemiological data from those countries. The limited studies report a very high incidence of candidemia and unique epidemiology with a different spectrum of Candida species. The recent global emergence of multi-drug resistant Candida auris is looming large as an important threat in hospitalized patients of developing countries. While managing candidemia cases in those countries several challenges are faced, which include poor infrastructure; compromised healthcare and infection control practices; misuse and overuse of antibiotics and steroids; lack of awareness in fungal infections; non-availability of advance diagnostic tests and antifungal drugs in many areas; poor compliance to antifungal therapy and stewardship program. Considering the above limitations, innovative strategies are required to reduce mortality due to candidemia in adults and neonates. In the present review, we have unraveled the challenges of candidemia faced by low resource countries and propose a ten part strategy to reduce mortality due candidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The incidence of candidaemia was higher in middle income countries and this can be linked to compromised healthcare systems, deficiency in resources, poor infection control implementation, unavailability of diagnostic tests allowing excess empirical therapy, impaired knowledge about fungal infections or misuse of antibiotics without stewardship programs [47].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 9×
“Population-based accurate data is also scarce from developed nations, as the majority of these studies are hospital-based or target specific patient groups, with the exceptions being France, Australia and Iceland [8].”
BackgroundInfluentialInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 10×
“Candida mannan and anti-mannan antibody detection have gained greater acceptance in Europe than the United States [80,81].”
BackgroundInfluentialEffectiveness of a hospital-wide programme to improve compliance with hand hygiene
Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02814-2 · Cited by 2,524
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“5–2 times patients survive) in adults in ICU [110,111,126].”
BackgroundGarey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 1×
“5–2 times patients survive) in adults in ICU [110,111,126].”
BackgroundAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Research works printed but not linked: 1
- Chakrabarti A. Fungal Infections in Asia: The Eastern Frontier of Mycology 1st ed. Elsevier Gurgaon, India 2013
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Preterm birth and sustained inflammation: consequences for the neonate
Humberg, A., Fortmann, I., Siller, B., Kopp, M. V., Herting, E., Göpel, W., Härtel, C., & German Neonatal Network, G. C. F. L. R. A. P. I. A. T. B. O. L. (. C. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00803-2 · Cited by 310
Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack
Singh, D. K., Tóth, R., & Gácser, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00094 · Cited by 119
“…2013) Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) FH and FHL-1, (Luo et al., 2013a) High-affinity glucose transporter 1(CaHgt1p) FH and C4BP (Lesiak-Markowicz et al., 2011; Kenno et al., 2019) FH and plasminogen remain functional and retain their protease activity (Poltermann et al., 2007).”
BackgroundKim, H. Y., Nguyen, T. A., Kidd, S. E., Chambers, J., Alastruey‐Izquierdo, A., Shin, J.-H., Dao, A., Forastiero, A., Wahyuningsih, R., Chakrabarti, A., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae042 · Cited by 123
Self-citationMathur, P., Hasan, F., Singh, P. K., Malhotra, R., Walia, K., & Chowdhary, A. (2018) · Mycoses · doi:10.1111/myc.12790 · Cited by 86
Global incidence and mortality of severe fungal disease
Ikuta, K. S., Meštrović, T., & Naghavi, M. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00102-6 · Cited by 66
Thomaz, D. Y., Del Negro, G. M. B., Ribeiro, L. B., da Silva, M., Carvalho, G. O. M. H., Camargo, C. H., de Almeida, J. N., Motta, A. L., Siciliano, R. F., Sejas, O. N. E., et al. (2022) · Journal of Fungi · doi:10.3390/jof8020100 · Cited by 64
Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study
Cook, A., Ferreras-Antolin, L., Adhisivam, B., Ballot, D. E., Berkley, J. A., Bernaschi, P., Carvalheiro, C. G., Chaikittisuk, N., Chen, Y., Chibabhai, V., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad010 · Cited by 67
Social determinants of health as drivers of fungal disease
Jenks, J. D., Prattes, J., Wurster, S., Sprute, R., Seidel, D., Oliverio, M., Egger, M., del Río, C., Sati, H. F., Cornely, O. A., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102325 · Cited by 76
“126 Overcrowded intensive care units, insuf fi cient air conditioning/ventilation systems, and lack of ef fi cient infection control services predispose individuals from lower income countries to a greater risk for hospital and ICU outbreaks of IFIs, as recently shown for COVID-19-associated…”
Neonatal invasive candidiasis: updates on clinical management and prevention
Kilpatrick, R., Scarrow, E. R., Hornik, C., & Greenberg, R. G. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00272-8 · Cited by 69
Nguyen, T. A., Kim, H. Y., STOCKER, S. L., Kidd, S. E., Alastruey‐Izquierdo, A., Dao, A., Harrison, T. S., Wahyuningsih, R., Rickerts, V., Perfect, J. R., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myad132 · Cited by 70
Teodoro, G. R., Gontijo, A. V. L., Salvador, M. J., Tanaka, M. H., Brighenti, F. L., Delbem, A. C. B., Delbem, Á. C. B., & Koga‐Ito, C. Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00647 · Cited by 49
Ahangarkani, F., Shokohi, T., Rezai, M. S., İlkit, M., Nesheli, H. M., Karami, H., Tamaddoni, A., Alizadeh‐Navaei, R., Khodavaisy, S., Meis, J. F. G. M., et al. (2020) · Mycoses · doi:10.1111/myc.13053 · Cited by 49
Kaur, H., Singh, S., Rudramurthy, S. M., Ghosh, A. K., Jayashree, M., Yaddanapudi, L. N., Ray, P., & Chakrabarti, A. (2020) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_20_112 · Cited by 50
Self-citationEpidemiology of Culture-confirmed Candidemia Among Hospitalized Children in South Africa, 2012–2017
Shuping, L., Mpembe, R. S., Mhlanga, M., Naicker, S. D., Maphanga, T. G., Tsotetsi, E., Wadula, J., Velaphi, S., Nakwa, F. L., Chibabhai, V., et al. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003151 · Cited by 47
Dantas-Medeiros, R., Zanatta, A. C., de Souza, L. B. F. C., Fernandes, J. M., Amorim-Carmo, B., Torres-Rêgo, M., Fernandes‐Pedrosa, M. D. F., Vilegas, W., Araújo, T. A. D. S., Michel, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.613155 · Cited by 42
Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: what do we know?
de Souza, C. M., dos Santos, M. M., Furlaneto-Maia, L., & Furlaneto, M. C. (2023) · Canadian Journal of Microbiology · doi:10.1139/cjm-2022-0195 · Cited by 44
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans
Capoci, I. R. G., Sakita, K. M., Faria, D. R., Rodrigues-Vendramini, F. A. V., Arita, G. S., de Oliveira, A. G., Felipe, M. S. S., Maigret, B., Mendonca, P., Kioshima, É. S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02130 · Cited by 36
“Fifty percent of global candidemia cases were reported in Asia, followed by the Americas, Europe, and Africa (Kaur and Chakrabarti, 2017).”
BackgroundProlonged Outbreak of Candida krusei Candidemia in Paediatric Ward of Tertiary Care Hospital
Kaur, H., Shankarnarayana, S. A., Hallur, V., Jayashree, M., Biswal, M., Ghosh, A. K., Ray, P., Chakrabarti, A., & Rudramurthy, S. M. (2020) · Mycopathologia · doi:10.1007/s11046-020-00427-y · Cited by 36
Self-citationSathyapalan, D. T., Antony, R., Nampoothiri, V., Kumar, A., Shashindran, N., James, J., Thomas, J., Prasanna, P., Sudhir, A. S., Philip, J. M., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06131-6 · Cited by 34
Study of Antifungal Susceptibility, Virulence Genes and Biofilm Formation in Candida albicans
Shrief, R., Zaki, M. E. S., El-Sehsah, E. M., Essa, S. G., & Mofreh, M. (2019) · The Open Microbiology Journal · doi:10.2174/1874285801913010241 · Cited by 37
Chakrabarti, A., Patel, A. K., Soman, R. N., & Todi, S. K. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2257895 · Cited by 27
Self-citationVega-Chacón, Y., de Albuquerque, M. C., Pavarina, A. C., Goldman, G. H., & Mima, E. G. D. O. (2021) · Virulence · doi:10.1080/21505594.2020.1868814 · Cited by 28
“In immunosuppressed patients, this infection can spread to the bloodstream causing candidemia, which is one of the main nosocomial infections associated with high mortality rates ranging from 25%-60% [3].”
BackgroundFungal Infections in COVID-19 Intensive Care Patients
Coşkun, A. S., & DURMAZ, Ş. Ö. (2021) · Polish Journal of Microbiology · doi:10.33073/pjm-2021-039 · Cited by 30
Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers
Kaur, G., Chawla, S., Kumar, P., & Singh, R. (2023) · Vaccines · doi:10.3390/vaccines11111658 · Cited by 29
“Ongoing clinical trials targeting high-risk groups, including the immunocompromised, strive to combat emerging fungal threats [119].”
BackgroundAgnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz‐Telles, F., Magri, M. M. C., Mendes, A. V. A., Camargo, L. F. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040468 · Cited by 30
Kumar, A., Nair, R., Kumar, M., Banerjee, A., Chakrabarti, A., Rudramurthy, S. M., Bagga, R., Gaur, N. A., Mondal, A. K., & Prasad, R. (2020) · Folia Microbiologica · doi:10.1007/s12223-020-00785-6 · Cited by 24
Self-citationPham, L. T. T., Pharkjaksu, S., Chongtrakool, P., Suwannakarn, K., & Ngamskulrungroj, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01194 · Cited by 23
“albicans (Kaur and Chakrabarti, 2017), were not available in our database.”
BackgroundInfluentialKhan, S., Cai, L., Bilal, H., Khan, M. N., Fang, W., Zhang, D., Yao, F., Wang, X., Wang, Q., Hou, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-92100-x · Cited by 20
Araujo, J. M., de Almeida, J. N., Magri, M. M. C., Costa, S. F., & Guimarães, T. (2024) · Journal of Fungi · doi:10.3390/jof10040268 · Cited by 18
“Comparing our incidence rate with developed and developing countries (including Brazil), our ID is well below [7].”
BackgroundMethodResultInfluentialLamba, M., Sharma, D. K., Sharma, R., Vyas, A., & Mamoria, V. P. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1670799 · Cited by 20
“These condition superadded by poor immunity in these infants makes them more prone toward Candida infection [9,10].”
BackgroundCandida bloodstream infection in patients with systemic autoimmune diseases
Vaquero-Herrero, M. P., Ragozzino, S., Iriart, X., Castaño-Romero, F., Sailler, L., Sánchez-González, R., Cassaing, S., Charpentier, É., Berry, A., Carbonell, C., et al. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.01.014 · Cited by 13
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates
Baltogianni, M. S., Giapros, V. I., & Dermitzaki, N. (2024) · Children · doi:10.3390/children11101207 · Cited by 20
“However, these assays are known to have a slow turnaround time and limited sensitivity and specificity [117,118].”
BackgroundSahoo, B., Goyal, R., Dutta, S., Joshi, P., & Sanyal, K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00079 · Cited by 15
Risk Factors for Mortality in Colombian Patients with Candidemia
Cortés, J. A., Montañez, A., Carreño-Gutiérrez, A. M., Reyes, P., Gómez, C., Pescador, A., Ariza, B., & Rosso, F. (2021) · Journal of Fungi · doi:10.3390/jof7060442 · Cited by 13
“In middle-income countries, such as those in Latin America, there has been a progressive change in epidemiology, with an increase in mortalities caused by cardiovascular causes, an increase in access to critical care units and an increase in the incidence of candidemia among such units [21].”
BackgroundUpdated Perspectives on the Diagnosis and Management of Neonatal Invasive Candidiasis
Daniel, K., Greenberg, R. G., Boutzoukas, A. E., & Katakam, L. I. (2023) · Research and Reports in Neonatology · doi:10.2147/rrn.s409779 · Cited by 16
“11,15 Over 20% of infants with invasive candidiasis die in spite of systemic antifungal treatment, and those who survive are at high risk for neurodevelopmental impairment.”
Husni, R., Chrabieh, R., Dib, R. W., Vázquez, J. A., Guimarães, T., Fernandez, A. R., Khoury, R., Asmar, L., Khazen, G., Samaha, N. L., et al. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.031 · Cited by 13
“Hence, the main micro-epidemiological changes in the intensive care and oncology units (to which most of our patients belonged) has been the change in the main type of candida species from C. albicans to C. non-albicans species, such as C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis.18-21 In the past, fluc…”
BackgroundInfluentialIncidence of ICU-Acquired Candidemia in a Tertiary Care Hospital in Cairo, Egypt
Abass, E., Mohamed, S., El-Kholy, I. M. A., & ZAKI, S. M. (2019) · Egyptian Journal of Microbiology · doi:10.21608/ejm.2019.14099.1104 · Cited by 12
Gebremicael, M. N., Nuttall, J. J. C., Tootla, H. D., Khumalo, A., Tooke, L., Salie, S., Muloiwa, R., Rhoda, N. R., Basera, W., & Eley, B. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08027-z · Cited by 11
“Good infection prevention practice, less crowded wards, better infrastructure and staffing resources, and presence of antifungal stewardship programmes are possible factors that contribute to lower incidence [26, 27].”
BackgroundGuideline Adherence and Outcomes of Patients with Candidemia in Brazil
Araujo, J. M., de Almeida, J. N., Magri, M. M. C., Costa, S. F., & Guimarães, T. (2024) · Journal of Fungi · doi:10.3390/jof10040282 · Cited by 11
“If the source of candidemia is the central venous catheter, its removal is essential [14].”
BackgroundPrevalence and Species Distribution of Neonatal Candidiasis: A Systematic Review and Meta-Analysis
Molla, A., & Albadrani, M. S. (2024) · Diseases · doi:10.3390/diseases12070154 · Cited by 11
“Vulnerable premature and low birth weight infants are at exceptionally high risk, with reported candidiasis incidence rates ranging from 7 to 20% in developing regions [3–5].”
BackgroundNeonatal Fungemia by Non-Candida Rare Opportunistic Yeasts: A Systematic Review of Literature
Mpakosi, A., Cholevas, V., Meletiadis, J., Theodoraki, M., & Sokou, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179266 · Cited by 14
“…a third-generation cephalosporin therapy, duration of treatment with a systemic broad-spectrum antibiotic for more than 10 days, fungal colonization, and the use of a central venous catheter, are additional factors for prophylactic administration of fluconazole in such vulnerable organisms [97].”
BackgroundQuantification of Factor H Mediated Self vs. Non-self Discrimination by Mathematical Modeling
Tille, A., Lehnert, T., Zipfel, P. F., & Figge, M. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01911 · Cited by 11
“The treatment of diseases caused by immune evasive pathogenic microbes becomes more and more important due to increasing case numbers (58) and rising mortality (59).”
BackgroundEpidemiological Attributes of Candida Species in Tropical Regions
Bohner, F., Gácser, A., & Tóth, R. (2021) · Current Tropical Medicine Reports · doi:10.1007/s40475-021-00226-5 · Cited by 11
Tsai, D. H., Wu, I. C.-Y., Chang, L.-F., Lu, M. J.-H., Debnath, B., Govender, N. P., Sharland, M., Warris, A., Hsia, Y., & Ferreras-Antolin, L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf329 · Cited by 10
“Globally, different epidemiology is observed with higher rates of non– albicans Candida isolates causing NIC in LMICs compared to HICs [19].”
Rattani, S., Farooqi, J. Q., Hussain, A. S., & Jabeen, K. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003161 · Cited by 10
“C is an emerging cause of increased morbidity, mortality and overall healthcare cost.(1) It is commonly encountered in premature infants, patient receiving long-term broad-spectrum antibiotics, immunocompromised individuals or post-abdominal surgeries.”
BackgroundMoni, M., Sidharthan, N., Sudhir, S., Prabhu, B., Nampoothiri, V., James, J., Philip, J. M., Thomas, J., Antony, R., Mohamed, Z. U., et al. (2022) · Medicine · doi:10.1097/md.0000000000028906 · Cited by 8
“The management of candidemia in low middle income countries (LMICs) is complicated by delayed diagnosis and subsequent lag in antifungal therapy initiation, along with inappropriate antifungal prescriptions such as incorrect dosing and durations.([2]) Although international guidelines for the management of candidemia,…”
Backgroundda Rocha, L. F., Pippi, B., Joaquim, A. R., de Andrade, S. F., & Fuentefría, A. M. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001377 · Cited by 10
Bohner, F., Papp, C., Takács, T., Varga, M., Szekeres, A., Nosanchuk, J. D., Vágvölgyi, C., Tóth, R., & Gácser, A. (2023) · Journal of Fungi · doi:10.3390/jof9121148 · Cited by 10
“%) among isolates, contributing to the global healthcare crisis C. auris has caused, especially in the developing world, where this antifungal is frequently the first empiric therapeutic choice for invasive fungal infection treatment [17,18].”
BackgroundSokou, R., Palioura, A. E., Konstantinidi, A., Lianou, A., Lampridou, M., Theodoraki, M., Piovani, D., Bonovas, S., Tsante, K. A., Ιωάννου, Π., et al. (2024) · Journal of Fungi · doi:10.3390/jof11010017 · Cited by 7
de Souza, C. M., Moralez, A. T. P., dos Santos, M. M., Mantovani, M. S., Furlaneto-Maia, L., & Furlaneto, M. C. (2022) · Mycopathologia · doi:10.1007/s11046-022-00663-4 · Cited by 8
Yerbanga, I. W., Diallo, S. N., Rouamba, T., Ouédraogo, D. F., Lagrou, K., Oladele, R. O., Gangneux, J., Denis, O., Rodriguez‐Villalobos, H., Montesinos, I., et al. (2024) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2024.121012 · Cited by 9
Bal, A. M. (2020) · Mycoses · doi:10.1111/myc.13196 · Cited by 6
Chemical composition, antifungal activity and toxicological evaluation of Lippia sidoides Cham
Oliveira, M. A., dos Santos, C. A. L., Teles, B. R. D. S., Oliveira, C. V. B., da Silva, V. B., Pereira, A. L. G., Rodrigues, V. L. C., Fonseca, V. J. A., Santana, M. D. S., Lima, C. M. G., et al. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2024.101333 · Cited by 6
Chakrabarti, A., Oladele, R. O., Hermsen, E. D., de Figueiredo, M. L. N., Muñóz, P., & Johnson, M. D. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2479011 · Cited by 9
“The reported incidence of candidemia in developing countries (lower-resource setting) ranges from 0.026–4.2 cases per 1000 admissions compared with 0.03–1.87 cases per 1000 admissions in developed countries (higher-resource setting) [4].”
InfluentialSelf-citationAnálise epidemiológica da candidemia e espécies fúngicas envolvidas
de Sousa, L. X., Sousa, L. C. O., Cruz, J. H. D. A., de Queiroz, R. G., Ribeiro, E. D., & Freire, J. C. P. (2020) · ARCHIVES OF HEALTH INVESTIGATION · doi:10.21270/archi.v9i6.4830 · Cited by 5
Gebretekle, G. B., Fentie, A. M., Gebremariam, G. T., Ali, E. E., Erku, D., Alemayehu, T., Abebe, W., & Sander, B. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08662-3 · Cited by 7
“Data on IC/C from low-and middle-income countries (LMICs) are scarce, but the few available studies demonstrate a high incidence and very high mortality rate [2, 5].”
BackgroundTanrıverdi, E. S., Yakupoğulları, Y., Duman, Y., Tekerekoğlu, M. S., & Otlu, B. (2025) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2025.04.004 · Cited by 4
Stergiou, K. I., Skourtsidis, K., Kiosis, G., Ioannou, D., Tseriotis, V., Fouskas, V., Karachrysafi, S., Iosifidis, Ε., Roilides, E., Papamitsou, T., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010228 · Cited by 5
Davari, A., Jafarzadeh, J., Hedayati, M. T., Shokohi, T., Abastabar, M., Nikmanesh, B., & Moazeni, M. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.2.10329 · Cited by 4
Epidemiology of Opportunist Fungal Infections in Asia
Chakrabarti, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9459-1_4 · Cited by 6
Self-citationRabault, C., Shuping, L., Mpembe, R. S., Quan, V., Lanternier, F., Lortholary, O., Paccoud, O., Govender, N. P., & GERMS-SA, F. (2025) · Emerging infectious diseases · doi:10.3201/eid3110.250359 · Cited by 3
“Consequently, the effect of AFR is greater in those settings ( 25 ), leading to a higher risk for treatment failure ( 26 ) and use of toxic drugs such as conventional amphotericin B ( 27 ).”
Hamed, S., & Emara, M. M. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00223-4 · Cited by 3
A Paradigm Shift in the Development of Anti-Candida Drugs
Gowda, D. V., Moin, A., Meenakshi, S. S., Manohar, M., Hemalatha, S., Siddaramaiah, H., Paranthaman, S., Rizvi, S. M. D., Hussain, T., & Kamal, M. A. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191029145209 · Cited by 3
Chiusaroli, L., Cozzolino, C., Cocchio, S., Saïa, M., Giaquinto, C., Donà, D., & Baldo, V. (2025) · Pathogens · doi:10.3390/pathogens14010093 · Cited by 2
“…is a documented infection in the neonatal phase of life with a variable incidence and mortality ranging from 12% to 37% in high-income countries (HICs) and from 8.9% to 75% in low-and middle-income countries (LMICs) [20], especially for prematurity with early gestational age and low weight [21].”
InfluentialDas, S., Singh, S., Tawde, Y., Spruijtenburg, B., Chakrabarti, A., Rudramurthy, S. M., Meis, J. F. G. M., de Groot, T., Meijer, E. F. J., Walia, K., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag257 · Cited by 3
Self-citationCandida: Friend and Foe of Humans
Bhakt, P., Battu, A., & Kaur, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-1577-0_22 · Cited by 2
Pietrobom, P. M. P., Truda, V. S. S., Fernández‐Ruiz, M., Gutiérrez, M. G., Sukiennik, T., Santos, D. W. D. C. L., Valerio, M., Gioia, F., Rodríguez‐Góncer, I., Giacobbe, D. R., et al. (2023) · Mycoses · doi:10.1111/myc.13669 · Cited by 1
Joshi, D. N., Archana, M., Gor, N. S., Bhavana, M. V., Adhikary, R., & Shenoy, B. (2025) · EMJ Microbiology & Infectious Diseases · doi:10.33590/emjmicrobiolinfectdis/hkmw5127 · Cited by 3
Sachdev, J., Gourav, S., Xess, I., Soneja, M., Punjadath, S., Siddharth, V., Pandey, M., Gupta, S., Manhas, A., Rana, B., et al. (2025) · Medical Mycology · doi:10.1093/mmy/myaf003 · Cited by 1
Prevalence of invasive yeast infections in a COVID-19 intensive care unit in northeastern Brazil
Medeiros, S. M. D. F. R. D. S., Júnior, S. D. D. C., Perez, V. P., Sousa, E. S. S., Campana, E. H., Araújo, M., Guerra, F. Q. S., Dejani, N. N., & Souto, F. O. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e13915 · Cited by 2
Challenges, Pitfalls, and Possible Solution for Asian Countries
Soman, R. N., & Sunavala, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9459-1_21 · Cited by 1
Candidíase e candidemia neonatal: Revisão de literatura
Luz, G. A., Schneider, G. C., & do Carmo, M. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14326 · Cited by 4
Castro, M. D. C. A., Inácio, C. P., de Lima-Neto, R. G., & Neves, R. P. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16731 · Cited by 1
Freire, J. C. P., Júnior, E. C. F., Melo, W. O. D. S., Costa, B. P., Ribeiro, A. D., Júnior, J. G. R., Costa, M. M. A., & Pereira, J. V. (2022) · Research Society and Development · doi:10.33448/rsd-v11i5.28170 · Cited by 4
Doorley, L. A. (2023) · doi:10.21007/etd.cghs.2023.0620 · Cited by 1
Wang, H., Xing, M., Ji, H., Cheng, Y., Hu, S., Wang, G., Zhou, S., Han, Y., Wang, C., Zha, L., et al. (2025) · medRxiv · doi:10.1101/2025.11.23.25340841 · Cited by 1
“[14] This rising burden is intrinsically linked to increasing antifungal resistance, necessitating enhanced global surveillance systems.”
InfluentialEvaluation of Candidemia Cases
Avcı, M., Güngör, S., Kutlu, H. H., & Eser, U. (2019) · International Journal of Scientific and Technological Research · doi:10.7176/jstr/5-12-18
Estudio de las comorbilidades y factores de riesgo en pacientes con candidemia
Herrero, M. D. L. P. V. (2020) · doi:10.14201/gredos.145314
Felix, G. N. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-16062023-113452 · Cited by 2
Araujo, J. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2023.tde-05022024-163245
Evaluation of the Level of Nurses' Awareness of Fungal Infections in Zahedan Educational Hospitals
Danesh, H. A., Mirtalebi, S., Keikha, N., Nabiolahi, A., & Aslani, P. (2024) · Annals of Military and Health Sciences Research · doi:10.5812/amh-150820
“A study by Kaur and Chakrabarti demonstrated that simple preventive measures, such as hand hygiene, environmental cleaning, and judicious use of antibiotics, can significantly reduce the prevalence of nosocomial fungal infections (20).”
Foresight Study of IoT Technology in Preventing Road Crash: A Case of Car Alcohol Detector
Ahmad, N., Nawanir, G., Azman, N. E. H., Seman, N. A. A., & Kamaruddin, N. K. (2024) · Journal of Advanced Research in Applied Sciences and Engineering Technology · doi:10.37934/araset.61.1.158175
“This would be impactful to increase living lifestyle among people that able to achieve goals successfully [58].”
BackgroundBurden of Invasive Candidiasis in West Africa: A Systematic Review and Meta-Analysis
Diallo, S. N., Yerbanga, I. W., Zango, S. H., Montesinos, I., Denis, O., Robert, A. R., Bamba, S., & Rodriguez‐Villalobos, H. (2024) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2024.1212023 · Cited by 1
Greenberg, R. G., Fisher, B. T., & Otto, W. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00217-x
Factors associated with Candida albicans dissemination via the intestinal mucosa
Rochac-Argueta, E. (2018) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/qgpt-gnkg
Dr.Karthik, R., Karjigi, S. K., & Bhattacharjee, D. (2025) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/r9tj5k68
Journal of Population Therapeutics and Clinical Pharmacology
Dr.Karthik, R., Karjigi, D. S. K., & Bhattacharjee, D. S. (2025) · doi:10.53555//r9tj5k68
Mofokeng, R., Bezuidenhout, C. C., & van Wyk, D. A. B. (2025) · Total Environment Microbiology · doi:10.1016/j.temicr.2025.100038 · Cited by 1
Oyedeji, O. A., Ogunyode, M. A., Sayomi, B. A., & Joel-Medewase, V. I. (2025) · Annals of African Medicine · doi:10.4103/aam.aam_63_25
Gebremicael, M. N., Nuttall, J. J. C., Tootla, H. D., Khumalo, A., Tooke, L., Salie, S., Muloiwa, R., Rhoda, N., Basera, W., & Eley, B. (2024) · Figshare · doi:10.6084/m9.figshare.26566034
Gebremicael, M. N., Nuttall, J. J. C., Tootla, H. D., Khumalo, A., Tooke, L., Salie, S., Muloiwa, R., Rhoda, N., Basera, W., & Eley, B. (2024) · Figshare · doi:10.6084/m9.figshare.26566037
A RARE CAUSE OF FUNGAL SEPSIS IN PRETERM NEONATE: A CASE REPORT AND LITERATURE REVIEW
Palić, I., & Gojić, S. (2026) · Preventive Paediatrics · doi:10.46793/pp251224021p
Nguyen, C. N. T., Nong, V. M., Doan, T. T., Pham, N. H., Truong, P. T., Do, T. V., Nguyen, T. T., Dao, C. X., Cuong, D. D., & Vu, G. V. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108895
Metadata
- Authors
- Kaur, H., & Chakrabarti, A.
- Affiliations
- Post Graduate Institute of Medical Education and Research (IN)
- Corresponding author
- Chakrabarti, Arunaloke
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2017-07-19
- Volume
- 3
- Issue
- 3
- Pages
- 41
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC5715942
- OpenAlex
- W2738952261
- Cited by
- 93
- References
- 146
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 8 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 5 · 2017: 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- candidemia, invasive fungal infections, mortality reduction, neonatal candidemia, Candida auris, drug resistance, resource-limited settings, developing countries, antifungal stewardship, infection control, antibiotic misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.